Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2002
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
A T van Oosterom, H T Mouridsen, O S Nielsen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 29, 2004
The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99
S C Darby, D M Keeling, R J D Spooner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer
P S Stonelake, P G Baker, W M Gillespie, et al.
AIDS (London, England)
|
April 20, 2004
The impact of HIV on mortality rates in the complete UK haemophilia population
Sarah C Darby, Sau Wan Kan, Rosemary J D Spooner, et al.
Lancet (London, England)
|
October 7, 1997
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
R L Souhami, A W Craft, J W Van der Eijken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology
H Martelli, O Oberlin, A Rey, et al.
British Journal of Cancer
|
January 11, 2007
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
S A Hussain, R Ganesan, G Reynolds, et al.
British Journal of Cancer
|
September 18, 2008
NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life
H M Earl, L Hiller, J A Dunn, et al.
Pediatric Hematology and Oncology
|
February 5, 1999
Pediatric oncology and hematology in Birmingham, England
J R Mann, P J Darbyshire, A Goodman, et al.
Lancet (London, England)
|
November 22, 2001
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial
J P Neoptolemos, J A Dunn, D D Stocken, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2002
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
A T van Oosterom, H T Mouridsen, O S Nielsen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 29, 2004
The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99
S C Darby, D M Keeling, R J D Spooner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer
P S Stonelake, P G Baker, W M Gillespie, et al.
AIDS (London, England)
|
April 20, 2004
The impact of HIV on mortality rates in the complete UK haemophilia population
Sarah C Darby, Sau Wan Kan, Rosemary J D Spooner, et al.
Lancet (London, England)
|
October 7, 1997
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
R L Souhami, A W Craft, J W Van der Eijken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology
H Martelli, O Oberlin, A Rey, et al.
British Journal of Cancer
|
January 11, 2007
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
S A Hussain, R Ganesan, G Reynolds, et al.
British Journal of Cancer
|
September 18, 2008
NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life
H M Earl, L Hiller, J A Dunn, et al.
Pediatric Hematology and Oncology
|
February 5, 1999
Pediatric oncology and hematology in Birmingham, England
J R Mann, P J Darbyshire, A Goodman, et al.
Lancet (London, England)
|
November 22, 2001
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial
J P Neoptolemos, J A Dunn, D D Stocken, et al.
Page
of 9